Testing effectiveness (Phase 2)Ended earlyNCT02794246What this trial is testingCART-19 Post-ASCT for Multiple MyelomaWho this might be right forMultiple Myeloma University of Pennsylvania 6
Testing effectiveness (Phase 2)Study completedNCT01177371What this trial is testingHigh-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin LymphomaWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+70 more Case Comprehensive Cancer Center 13
Testing effectiveness (Phase 2)Ended earlyNCT00275262What this trial is testingEvaluate the Ability of Lupron Depot to Enhance Immune Function Following Bone Marrow TransplantationWho this might be right forHodgkin DiseaseLymphoma, Non-HodgkinMultiple Myeloma+1 more Abbott 25
Large-scale testing (Phase 3)Looking for participantsNCT06895538What this trial is testingComparison of ATLG and ATG for Immune Reconstitution After Allo-HSCT for Hematologic MalignancyWho this might be right forLeukemiaMDSLymphoma Peking University First Hospital 24
Testing effectiveness (Phase 2)Looking for participantsNCT06376526What this trial is testingIMMUNOPLANT for Newly Diagnosed Multiple MyelomaWho this might be right forMultiple Myeloma Dickran Kazandjian, MD 150
Testing effectiveness (Phase 2)Ended earlyNCT01195480What this trial is testingCD19-CAR Immunotherapy for Childhood Acute Lymphoblastic Leukemia (ALL)Who this might be right forAcute Lymphoblastic Leukemia University College, London 29
Early research (Phase 1)Study completedNCT04634435What this trial is testingAutologous Memory-like NK Cell Therapy With BHV-1100 and Low Dose IL-2 in Multiple Myeloma PatientsWho this might be right forMultiple Myeloma Biohaven Pharmaceuticals, Inc. 7
Early research (Phase 1)Study completedNCT01158274What this trial is testingRO4929097 and Capecitabine in Treating Patients With Refractory Solid TumorsWho this might be right forAdult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell LymphomaAIDS-related Diffuse Large Cell Lymphoma+83 more National Cancer Institute (NCI) 30
Early research (Phase 1)Study completedNCT02512497What this trial is testingRomidepsin Maintenance After Allogeneic Stem Cell TransplantationWho this might be right forCutaneous T-cell LymphomaT-Prolymphocytic LeukemiaT-Large Granulocytic Leukemia+2 more Ohio State University Comprehensive Cancer Center 23
Not applicableStudy completedNCT00569309What this trial is testingImmune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk LymphomaWho this might be right forLymphomaMultiple Myeloma and Plasma Cell NeoplasmSmall Intestine Cancer Ohio State University Comprehensive Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT00003887What this trial is testingLymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell TransplantationWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more Fred Hutchinson Cancer Center
Not applicableStudy completedNCT01172132What this trial is testingThe Use of Intensive Care in Critically Ill Cancer Haematological Patients: "TRIAL-OH"Who this might be right forHematological Malignancies Assistance Publique - Hôpitaux de Paris 1,011
Large-scale testing (Phase 3)Study completedNCT01016548What this trial is testingEvaluation of Influenza H1N1 Vaccine in Adults With Lymphoid Malignancies on ChemotherapyWho this might be right forLymphomaMultiple MyelomaInfluenza A Virus, H1N1 Subtype University Health Network, Toronto 42
Very early researchStudy completedNCT01174940What this trial is testingTest Extracorporeal Photopheresis (ECP) Treatment Before/After Allogeneic Bone Marrow Transplant (BMT) or Peripheral Blood Stem Cell (PBSC) Transplant to Prevent Graft Versus Host DiseaseWho this might be right forStem Cell Leukemia of Unclear LineageGraft Versus Host Disease University of Kansas Medical Center 22
Testing effectiveness (Phase 2)Study completedNCT01075321What this trial is testingEverolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin LymphomaWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+16 more Mayo Clinic 58
Early research (Phase 1)Ended earlyNCT01251952What this trial is testingDose Escalation Trial of Denileukin Diftitox (Ontak) Post Autologous TransplantationWho this might be right forMultiple Myeloma Barbara Ann Karmanos Cancer Institute 2
Early research (Phase 1)Study completedNCT01768338What this trial is testingRecombinant Human IL-18 and Ofatumumab After PBSCT for LymphomaWho this might be right forNon-Hodgkin's Lymphoma Michael John Robertson 9
Testing effectiveness (Phase 2)Looking for participantsNCT06686108What this trial is testingDemethylating Agents Combined With Venetoclax for High-risk T-cell Lymphoblastic Lymphoma/Leukemia Post-Transplant Relapse PreventionWho this might be right forT-cell Acute Lymphoblastic LeukemiaALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATIONRelapse Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 59
Not applicableUnknownNCT04489264What this trial is testingThe Role of Consolidative Autologous Stem Cell Transplantation After First-line Therapy in Peripheral T Cell LymphomaWho this might be right forPeripheral T Cell Lymphoma Peking University 60
Large-scale testing (Phase 3)Active Not RecruitingNCT06045806What this trial is testingCompare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Therapy Versus Lenalidomide Maintenance Therapy Alone in Adult Participants With Newly Diagnosed Multiple Myeloma Who Have Suboptimal Response After Autologous Stem Cell TransplantationWho this might be right forMultiple Myeloma Celgene 79